As of Feb 21
| +1.71 / +1.51%|
The 22 analysts offering 12-month price forecasts for Bayer have a median target of 116.43, with a high estimate of 139.00 and a low estimate of 93.38. The median estimate represents a +1.24% increase from the last price of 115.00.
The current consensus among 22 polled investment analysts is to Buy stock in Bayer. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.